| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 54 | 2022 | 454 | 5.900 |
Why?
|
| Genome-Wide Association Study | 45 | 2022 | 1535 | 3.470 |
Why?
|
| Homosexuality, Male | 7 | 2021 | 255 | 2.510 |
Why?
|
| Heterosexuality | 4 | 2021 | 16 | 1.820 |
Why?
|
| Polymorphism, Single Nucleotide | 40 | 2022 | 2303 | 1.750 |
Why?
|
| Gender Identity | 2 | 2021 | 42 | 1.620 |
Why?
|
| Genetic Linkage | 18 | 2021 | 618 | 1.460 |
Why?
|
| Genetic Predisposition to Disease | 35 | 2022 | 2193 | 1.400 |
Why?
|
| Mental Disorders | 9 | 2021 | 362 | 1.280 |
Why?
|
| Genome, Human | 12 | 2021 | 740 | 0.960 |
Why?
|
| Depressive Disorder, Major | 7 | 2021 | 138 | 0.910 |
Why?
|
| Bipolar Disorder | 15 | 2021 | 373 | 0.860 |
Why?
|
| Genetic Variation | 12 | 2018 | 1343 | 0.810 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2022 | 89 | 0.710 |
Why?
|
| DNA Copy Number Variations | 10 | 2022 | 169 | 0.680 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2014 | 86 | 0.680 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 202 | 0.650 |
Why?
|
| General Practitioners | 1 | 2016 | 8 | 0.630 |
Why?
|
| Transcriptome | 4 | 2018 | 527 | 0.630 |
Why?
|
| Humans | 97 | 2022 | 81308 | 0.630 |
Why?
|
| Whole Exome Sequencing | 1 | 2017 | 94 | 0.620 |
Why?
|
| Genotype | 22 | 2019 | 1810 | 0.610 |
Why?
|
| Male | 51 | 2021 | 39770 | 0.610 |
Why?
|
| Chromosome Mapping | 19 | 2015 | 1067 | 0.580 |
Why?
|
| Gene Expression Regulation | 7 | 2018 | 1891 | 0.560 |
Why?
|
| Chromosomes, Human, X | 1 | 2014 | 50 | 0.540 |
Why?
|
| Patient Participation | 1 | 2016 | 197 | 0.530 |
Why?
|
| Family | 3 | 2009 | 303 | 0.530 |
Why?
|
| Sexual Behavior | 3 | 2021 | 276 | 0.530 |
Why?
|
| Referral and Consultation | 1 | 2016 | 307 | 0.510 |
Why?
|
| Communication | 1 | 2016 | 399 | 0.480 |
Why?
|
| Female | 47 | 2021 | 42685 | 0.460 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 1327 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 6 | 6 | 2009 | 125 | 0.450 |
Why?
|
| Parity | 1 | 2012 | 89 | 0.450 |
Why?
|
| Receptors, Serotonin | 2 | 2002 | 35 | 0.450 |
Why?
|
| Phenotype | 10 | 2021 | 2292 | 0.450 |
Why?
|
| Alleles | 14 | 2022 | 1097 | 0.450 |
Why?
|
| Chromatin | 3 | 2020 | 343 | 0.450 |
Why?
|
| Fertility | 1 | 2012 | 98 | 0.450 |
Why?
|
| Case-Control Studies | 13 | 2019 | 1747 | 0.440 |
Why?
|
| Multifactorial Inheritance | 4 | 2019 | 142 | 0.440 |
Why?
|
| Siblings | 3 | 2021 | 109 | 0.430 |
Why?
|
| Linkage Disequilibrium | 13 | 2016 | 465 | 0.420 |
Why?
|
| Mothers | 1 | 2012 | 130 | 0.420 |
Why?
|
| Decision Making | 1 | 2016 | 604 | 0.420 |
Why?
|
| Quantitative Trait Loci | 6 | 2020 | 555 | 0.420 |
Why?
|
| Genetic Loci | 4 | 2017 | 238 | 0.410 |
Why?
|
| Haplotypes | 7 | 2008 | 633 | 0.410 |
Why?
|
| Genetic Markers | 10 | 2016 | 473 | 0.390 |
Why?
|
| Psychotic Disorders | 4 | 2021 | 174 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2005 | 43 | 0.350 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2008 | 65 | 0.350 |
Why?
|
| Adult | 23 | 2018 | 24771 | 0.340 |
Why?
|
| Internet | 1 | 2010 | 306 | 0.330 |
Why?
|
| Lod Score | 9 | 2021 | 150 | 0.320 |
Why?
|
| Genetics, Behavioral | 2 | 2004 | 22 | 0.320 |
Why?
|
| Body Height | 3 | 2013 | 98 | 0.320 |
Why?
|
| Pedigree | 15 | 2012 | 962 | 0.310 |
Why?
|
| Brain | 6 | 2020 | 2053 | 0.310 |
Why?
|
| Body Mass Index | 4 | 2015 | 745 | 0.290 |
Why?
|
| Sequence Deletion | 2 | 2019 | 206 | 0.290 |
Why?
|
| Base Sequence | 9 | 2017 | 2332 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 1 | 2005 | 161 | 0.260 |
Why?
|
| Gene Frequency | 10 | 2014 | 663 | 0.260 |
Why?
|
| Phosphoproteins | 1 | 2005 | 252 | 0.250 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 282 | 0.250 |
Why?
|
| Middle Aged | 15 | 2018 | 24127 | 0.250 |
Why?
|
| Psychopharmacology | 1 | 2002 | 25 | 0.240 |
Why?
|
| Population Health | 1 | 2022 | 24 | 0.230 |
Why?
|
| Schizophrenic Psychology | 2 | 2012 | 127 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 13 | 3 | 2017 | 51 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 18 | 6 | 1999 | 43 | 0.220 |
Why?
|
| Suicide, Attempted | 2 | 2021 | 125 | 0.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 76 | 0.220 |
Why?
|
| Biological Evolution | 1 | 2009 | 877 | 0.210 |
Why?
|
| Nicotine | 2 | 2021 | 190 | 0.210 |
Why?
|
| Sex Characteristics | 2 | 2021 | 297 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2016 | 63 | 0.210 |
Why?
|
| Sexual Partners | 1 | 2021 | 89 | 0.200 |
Why?
|
| Adolescent | 10 | 2018 | 8736 | 0.200 |
Why?
|
| Choice Behavior | 1 | 2021 | 155 | 0.200 |
Why?
|
| Proteome | 1 | 2001 | 108 | 0.190 |
Why?
|
| Risk Factors | 8 | 2021 | 5177 | 0.190 |
Why?
|
| Homosexuality, Female | 1 | 2019 | 13 | 0.190 |
Why?
|
| Behavior, Addictive | 1 | 2021 | 117 | 0.180 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 140 | 0.180 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 3 | 2003 | 8 | 0.180 |
Why?
|
| Dopamine Antagonists | 1 | 2018 | 34 | 0.180 |
Why?
|
| Dopamine | 2 | 2018 | 268 | 0.170 |
Why?
|
| X Chromosome Inactivation | 1 | 2017 | 27 | 0.170 |
Why?
|
| Smoking | 2 | 2012 | 600 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2017 | 49 | 0.170 |
Why?
|
| Receptors, Thyrotropin | 1 | 2017 | 54 | 0.170 |
Why?
|
| Body Size | 2 | 2015 | 83 | 0.160 |
Why?
|
| Chromosomes, Human | 3 | 2009 | 65 | 0.160 |
Why?
|
| DNA | 2 | 2002 | 1258 | 0.160 |
Why?
|
| Neurogenesis | 1 | 2018 | 76 | 0.160 |
Why?
|
| Informed Consent | 1 | 2019 | 247 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 2 | 2016 | 65 | 0.160 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1997 | 97 | 0.160 |
Why?
|
| Hippocampus | 1 | 2001 | 431 | 0.160 |
Why?
|
| Nervous System | 1 | 2017 | 77 | 0.160 |
Why?
|
| Brain Diseases | 1 | 2018 | 174 | 0.160 |
Why?
|
| Genome | 1 | 2019 | 347 | 0.160 |
Why?
|
| Prader-Willi Syndrome | 1 | 2016 | 8 | 0.150 |
Why?
|
| Angelman Syndrome | 1 | 2016 | 7 | 0.150 |
Why?
|
| Paternal Inheritance | 1 | 2016 | 3 | 0.150 |
Why?
|
| Obesity | 3 | 2013 | 927 | 0.150 |
Why?
|
| Models, Genetic | 3 | 2016 | 896 | 0.150 |
Why?
|
| Neurons | 3 | 2022 | 1500 | 0.150 |
Why?
|
| Cell Line | 3 | 2018 | 2474 | 0.150 |
Why?
|
| Statistics as Topic | 1 | 2017 | 234 | 0.150 |
Why?
|
| Fetus | 2 | 2016 | 215 | 0.150 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 81 | 0.150 |
Why?
|
| Educational Status | 1 | 2016 | 169 | 0.140 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 70 | 0.140 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2012 | 476 | 0.140 |
Why?
|
| Educational Measurement | 1 | 2016 | 206 | 0.140 |
Why?
|
| Young Adult | 6 | 2018 | 5754 | 0.140 |
Why?
|
| United Kingdom | 3 | 2021 | 159 | 0.140 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 3054 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2013 | 79 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2011 | 54 | 0.130 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2015 | 154 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2017 | 1172 | 0.130 |
Why?
|
| Williams Syndrome | 1 | 2013 | 4 | 0.130 |
Why?
|
| Autistic Disorder | 2 | 2012 | 141 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2017 | 511 | 0.130 |
Why?
|
| United States | 6 | 2022 | 6191 | 0.120 |
Why?
|
| Hydroxymethylbilane Synthase | 1 | 1993 | 1 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2013 | 79 | 0.120 |
Why?
|
| Anthropometry | 1 | 2013 | 75 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 832 | 0.120 |
Why?
|
| Aged | 8 | 2018 | 17570 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2022 | 2600 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 342 | 0.110 |
Why?
|
| Gene Expression | 5 | 2010 | 1285 | 0.110 |
Why?
|
| Europe | 5 | 2012 | 303 | 0.110 |
Why?
|
| Apoptosis | 1 | 2018 | 1655 | 0.110 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 129 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2012 | 107 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 496 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 436 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2002 | 99 | 0.100 |
Why?
|
| Polymorphism, Genetic | 3 | 2004 | 813 | 0.100 |
Why?
|
| Self-Assessment | 1 | 2010 | 46 | 0.100 |
Why?
|
| Personality Assessment | 1 | 2010 | 96 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 73 | 0.100 |
Why?
|
| Risk | 3 | 2020 | 673 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 226 | 0.100 |
Why?
|
| Amino Acid Sequence | 4 | 2002 | 2079 | 0.100 |
Why?
|
| African Americans | 6 | 2022 | 1079 | 0.100 |
Why?
|
| Gene-Environment Interaction | 3 | 2016 | 96 | 0.100 |
Why?
|
| Birth Order | 1 | 2009 | 8 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2011 | 221 | 0.090 |
Why?
|
| Alcoholism | 1 | 2011 | 160 | 0.090 |
Why?
|
| Hair | 1 | 2009 | 54 | 0.090 |
Why?
|
| Body Weight | 1 | 2010 | 458 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 11 | 0.090 |
Why?
|
| RNA | 1 | 2013 | 522 | 0.090 |
Why?
|
| RNA Stability | 2 | 2013 | 86 | 0.090 |
Why?
|
| Functional Laterality | 1 | 2009 | 198 | 0.090 |
Why?
|
| Quality Control | 1 | 2008 | 113 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 106 | 0.080 |
Why?
|
| Neoplasms | 1 | 2022 | 2700 | 0.080 |
Why?
|
| Synapses | 2 | 2022 | 280 | 0.080 |
Why?
|
| Age of Onset | 4 | 2012 | 311 | 0.080 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2001 | 148 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2003 | 1938 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 3 | 2013 | 94 | 0.080 |
Why?
|
| Genomics | 2 | 2022 | 644 | 0.080 |
Why?
|
| Prevalence | 1 | 2010 | 1190 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 105 | 0.070 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2005 | 2 | 0.070 |
Why?
|
| Armadillo Domain Proteins | 1 | 2005 | 3 | 0.070 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2005 | 4 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 918 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2001 | 761 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 3586 | 0.070 |
Why?
|
| Pregnancy | 1 | 2012 | 2724 | 0.070 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 18 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1419 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2007 | 664 | 0.060 |
Why?
|
| Receptors, Dopamine | 1 | 2003 | 40 | 0.060 |
Why?
|
| Nucleic Acid Conformation | 2 | 2003 | 326 | 0.060 |
Why?
|
| Disease Susceptibility | 3 | 1998 | 182 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 651 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2013 | 3167 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 47 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 376 | 0.050 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 6 | 0.050 |
Why?
|
| Electrophoresis | 1 | 2001 | 55 | 0.050 |
Why?
|
| Mental Health | 1 | 2022 | 145 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2021 | 159 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1427 | 0.050 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 58 | 0.050 |
Why?
|
| Problem Solving | 1 | 2021 | 53 | 0.050 |
Why?
|
| Computational Biology | 2 | 2016 | 519 | 0.050 |
Why?
|
| Adoption | 2 | 2011 | 8 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2001 | 114 | 0.050 |
Why?
|
| Microsatellite Repeats | 4 | 2002 | 143 | 0.050 |
Why?
|
| Sp4 Transcription Factor | 2 | 2010 | 2 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 1997 | 54 | 0.050 |
Why?
|
| Logistic Models | 3 | 2011 | 1117 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 683 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 1997 | 392 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2019 | 67 | 0.050 |
Why?
|
| Mutation | 2 | 2003 | 3791 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2022 | 288 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6244 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2021 | 396 | 0.040 |
Why?
|
| RNA Editing | 1 | 1998 | 19 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 260 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 1998 | 52 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 682 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 2017 | 17 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 124 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1997 | 47 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1996 | 30 | 0.040 |
Why?
|
| Genes | 1 | 1998 | 304 | 0.040 |
Why?
|
| Multigene Family | 1 | 1997 | 200 | 0.040 |
Why?
|
| Dendrites | 1 | 2017 | 98 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1997 | 126 | 0.040 |
Why?
|
| Gene Library | 1 | 1997 | 126 | 0.040 |
Why?
|
| Animals | 4 | 2021 | 25878 | 0.040 |
Why?
|
| Chromosome Duplication | 1 | 2016 | 8 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1996 | 51 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 620 | 0.040 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 32 | 0.040 |
Why?
|
| Neuregulin-1 | 2 | 2006 | 13 | 0.040 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 36 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2008 | 47 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 796 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2310 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 3944 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1996 | 931 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 258 | 0.030 |
Why?
|
| Nuclear Family | 3 | 2000 | 89 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 3955 | 0.030 |
Why?
|
| Sweden | 1 | 2013 | 41 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 336 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2013 | 60 | 0.030 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 39 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 48 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1451 | 0.030 |
Why?
|
| Base Composition | 1 | 2013 | 32 | 0.030 |
Why?
|
| HapMap Project | 1 | 2013 | 47 | 0.030 |
Why?
|
| Half-Life | 1 | 2013 | 98 | 0.030 |
Why?
|
| Genetic Carrier Screening | 1 | 1993 | 61 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2013 | 38 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1120 | 0.030 |
Why?
|
| Adolescent Development | 1 | 2012 | 18 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 100 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1545 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 1056 | 0.030 |
Why?
|
| Cognition | 1 | 2016 | 502 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 177 | 0.030 |
Why?
|
| Genes, Recessive | 2 | 2002 | 84 | 0.030 |
Why?
|
| Twin Studies as Topic | 1 | 2011 | 19 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2011 | 23 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 1803 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 900 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 291 | 0.030 |
Why?
|
| Random Allocation | 1 | 2011 | 335 | 0.030 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2009 | 17 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 652 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2012 | 253 | 0.020 |
Why?
|
| Twins | 1 | 2010 | 65 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 94 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 953 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2009 | 51 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2017 | 1482 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 150 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2009 | 82 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 302 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2012 | 379 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2330 | 0.020 |
Why?
|
| Environment | 1 | 2010 | 212 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1787 | 0.020 |
Why?
|
| Dysbindin | 1 | 2007 | 2 | 0.020 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2007 | 2 | 0.020 |
Why?
|
| Recurrence | 1 | 2010 | 1116 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2013 | 743 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1698 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 1025 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2003 | 47 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2003 | 65 | 0.020 |
Why?
|
| CHO Cells | 1 | 2003 | 188 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 114 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2003 | 90 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2004 | 253 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 561 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 519 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 277 | 0.010 |
Why?
|
| Africa | 1 | 2002 | 92 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 869 | 0.010 |
Why?
|
| Australia | 1 | 2002 | 94 | 0.010 |
Why?
|
| Child | 1 | 2013 | 6639 | 0.010 |
Why?
|
| Canada | 1 | 2002 | 195 | 0.010 |
Why?
|
| Family Health | 1 | 2001 | 161 | 0.010 |
Why?
|
| Infant | 2 | 1998 | 2965 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2000 | 43 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 372 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2000 | 116 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2000 | 90 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2000 | 107 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 693 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 2160 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1997 | 11 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1997 | 36 | 0.010 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 1997 | 22 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1997 | 32 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1997 | 72 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1997 | 47 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1997 | 7 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1997 | 58 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1997 | 86 | 0.010 |
Why?
|
| Receptors, Dopamine D3 | 1 | 1996 | 15 | 0.010 |
Why?
|
| Introns | 1 | 1998 | 283 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1997 | 253 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1998 | 194 | 0.010 |
Why?
|
| Homozygote | 1 | 1996 | 197 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 132 | 0.010 |
Why?
|
| Exons | 1 | 1998 | 444 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1998 | 744 | 0.010 |
Why?
|
| Heterozygote | 1 | 1996 | 358 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1999 | 571 | 0.010 |
Why?
|
| Risk Assessment | 1 | 1996 | 2180 | 0.010 |
Why?
|